United States  

What's ahead after the Purdue tentative settlement

SeattlePI.com Wednesday, 11 September 2019
CLEVELAND (AP) — Wednesday's tentative $12 billion settlement by some state, local and tribal governments with Purdue Pharma, the manufacturer of OxyContin, and the company's owners could shape efforts to reach a global settlement with other manufacturers, drug distributors and retailers in lawsuits consolidated before a federal judge in Cleveland. The lawsuits aim to find help for communities besieged by an opioid crisis that has killed 400,000 people across the U.S. since 2000.

Here are some questions and answers about Purdue Pharma, the proposed settlement, and its importance to the multi-district litigation in Cleveland.

___

WHAT IS PURDUE PHARMA?

It's a privately held company based in Stamford, Connecticut, owned by the ultra-wealthy Sackler family. It employees thousands of people worldwide and controls numerous subsidiaries. The tentative settlement calls for the money to be paid out over time with the Sacklers relinquishing control of the company.

___

WHY IS A SETTLEMENT WITH PURDUE IMPORTANT?

OxyContin is a time-release painkiller that's been blamed for triggering the nation's opioid crisis that began taking hold in the early 2000s, an assertion Purdue vehemently disagrees with. Purdue in 2007 pleaded guilty to misleading doctors, patients and regulators about the drug's risks and paid a $634 million fine. It's believed the Sacklers have removed billions of dollars from the company since 2007 and have shielded that wealth in an intricate web of offshore companies and trusts. While an ultimate settlement if reached could include a prepackaged bankruptcy, without a deal the company could file a free-fall bankruptcy that would greatly reduce the amount of money governments had hoped to receive to address the crisis. And generally, family owned businesses...
0
shares
ShareTweetSavePostSend
 
Video credit: Reuters Studio - Published
News video: Purdue reaches tentative opioid settlement -sources

Purdue reaches tentative opioid settlement -sources 00:45

OxyContin maker Purdue Pharma reached a tentative agreement with some plaintiffs to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing its settlement offer in bankruptcy proceedings starting as soon as next week, people...

You Might Like


Related videos from verified sources

Wisconsin will not join tentative settlement agreement with Purdue Pharma [Video]

Wisconsin will not join tentative settlement agreement with Purdue Pharma

As OxyContin manufacturer Purdue Pharma files for bankruptcy, some states have not signed on to a tentative settlement agreement.

Credit: WKBTPublished
Purdue Pharma Files for Bankruptcy [Video]

Purdue Pharma Files for Bankruptcy

Purdue Pharma Files for Bankruptcy . The maker of OxyContin filed for Chapter 11 bankruptcy protection on Sunday. . A tentative settlement was made last week with more than 2,000 local..

Credit: Wibbitz Top Stories     Duration: 01:43Published
OxyContin Maker Purdue Pharma Files For Chapter 11 as Part of Settlement Agreement [Video]

OxyContin Maker Purdue Pharma Files For Chapter 11 as Part of Settlement Agreement

OxyContin maker Purdue Pharma filed for Chapter 11 bankruptcy protection as part of its settlement amid a rampant opioid addiction crisis. Nathan Rousseau Smith has the story.

Credit: Veuer     Duration: 01:25Published

Related news from verified sources

Purdue Pharma files for bankruptcy amid numerous lawsuits over opioid epidemic

Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy late Sunday. The move came days after Purdue...
CBS News Also reported by •SeattlePI.comSeattle TimesUSATODAY.com

The Latest: Attorneys general are split on opioid settlement

HARTFORD, Conn. (AP) — The Latest on a tentative settlement between governments and OxyContin maker Purdue Pharma (all times local): ___ 5:05...
SeattlePI.com Also reported by •Seattle TimesUSATODAY.com

Report: Opioids settlement won’t fix areas hardest hit

A new analysis finds that money from a tentative settlement with OxyContin maker Purdue Pharma will be “no more than a stopgap” for state and local...
Seattle Times Also reported by •Newsmax

Tweets about this